Patients should also inform their healthcare provider if they have any other medical conditions, are pregnant or planning to become pregnant, or are breastfeeding
Ahmedabad-based Zydus Lifesciences has launched Semaglutide Injection under the brand names SEMAGLYN, MASHEMA and ALTERME, upon patent expiry in India
Li Y, Zeng X, Lu D, Yin M, Shan M, Gao Y
Patterns of discontinuation in GLP-1 agonists
Toxicity appears low, but long-term human safety is unknown
IL-1beta promotes IL-17A production of ILC3s to aggravate neutrophilic airway inflammation in mice